Humacyte HUMA
NASDAQ HUMA
$0.50 -0.01 (-2.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Humacyte (HUMA) Selling, General & Administrative (2020 - 2026)

Updated

Humacyte's Selling, General & Administrative came in at $8.03 million for Q2 2026, up 2.8% from $7.81 million a year earlier and up 1.2% from the prior quarter.

Analysis

Humacyte (HUMA) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Humacyte reported Selling, General & Administrative of $31.18 million, up 1.6% year-over-year; for FY2025, it came in at $31.17 million, up 20.8% from FY2024.

  • Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $25.8 million in FY2024 (+9.8%), $23.5 million in FY2023 (+2.7%), $22.88 million in FY2022 (+8.3%) and $21.13 million in FY2021 (+75.9%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q1 2025.
  • Year-over-year, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 17.5%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2021 (growth of 113.9%), and the weakest in Q1 2023 (a decline of 7.9%).
  • Business Quant data shows HUMA's Selling, General & Administrative at $7.93 million (Q1 2026), $7.62 million (Q4 2025) and $7.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00 8.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.03 Mn
Mar 31, 2026 7.93 Mn
Dec 31, 2025 7.62 Mn
Sep 30, 2025 7.61 Mn
Jun 30, 2025 7.81 Mn
Mar 31, 2025 8.14 Mn
Dec 31, 2024 7.43 Mn
Sep 30, 2024 7.31 Mn
Jun 30, 2024 5.75 Mn
Mar 31, 2024 5.31 Mn
Dec 31, 2023 6.00 Mn
Sep 30, 2023 6.07 Mn
Jun 30, 2023 6.19 Mn
Mar 31, 2023 5.23 Mn
Dec 31, 2022 5.83 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 5.18 Mn
Mar 31, 2022 5.68 Mn
Dec 31, 2021 5.55 Mn
Sep 30, 2021 5.40 Mn
API Access

Humacyte Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HUMA&period=max&api_key=YOUR_API_KEY